ClinicalTrials.govpublic full text
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
pancreatic cancer, pd-l1, pd-1 inhibitor, ldrt, proterizumab
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 226236
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.